Mismatches between standard discharge and expert recommendations are linked to worse functional outcomes and higher 3-month ...

Healthcare institutions delete records of patient encounters, common cardiology patients are underrepresented in clinical trials, and a medical device is less accurate in patients with darker skin.

After adjustment for other factors, a CFS of 3 or higher and relapsed/refractory disease were the only independent predictors of early zanubrutinib discontinuation.

Health experts say struggling with a simple 10-second balance test at home may indicate increased fall risk and other health ...

Researchers sought to determine whether zanubrutinib combined with rituximab and lenalidomide would improve remission rates in older adults with newly diagnosed DLBCL.

While there’s no crystal ball to predict your future health, there are a few basic tests you can give yourself to gauge your current strength, power, cardiovascular fitness and balance — all of which ...

Global Radiopharmaceuticals Market Size The global Radiopharmaceuticals market revenue was USD 6761 Million in 2022 and is ...

Leukemoid reaction, a non-malignant leucocytosis (total leucocyte count≥30 000–50 000 /mm³) is typically triggered by infection, malignancy or drug exposure. Its occurrence after intravenous iron ...

Judith and Matthew are among the eight million people in Canada aged 65 and older. In recent months, both noticed subtle ...

Due to the National Medical Commission (NMC) approval for the inclusion of additional postgraduate medical seats to the ...

Johns Hopkins Artificial Intelligence and Technology Collaboratory for Aging Research awards grants to research teams across the country in its fifth round of funding ...